{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:07:25Z","timestamp":1787843245703,"version":"build-2784847793"},"reference-count":45,"publisher":"e-Century Publishing Corporation","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cancer Res"],"DOI":"10.62347\/vxbp2060","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T03:33:23Z","timestamp":1764732803000},"page":"4885-4904","source":"Crossref","is-referenced-by-count":1,"title":["Role and mechanism of the CBX4-HDAC5-CERS6 axis in disrupting sphingomyelin metabolism in acute myeloid leukemia"],"prefix":"10.62347","volume":"15","author":[{"given":"Ruifang","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1038\/s41375-025-02645-z","article-title":"Targeting lipid metabolism in acute myeloid leukemia: biological insights and therapeutic opportunities","volume":"39","author":"Dembitz","year":"2025","unstructured":"Dembitz V, James SC and Gallipoli P. Targeting lipid metabolism in acute myeloid leukemia: biological insights and therapeutic opportunities. Leukemia 2025; 39: 1814-1823.","journal-title":"Leukemia"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1053\/j.seminhematol.2025.06.003","article-title":"Epigenetic dysregulation in acute myeloid leukemia","volume":"62","author":"Schrezenmeier","year":"2025","unstructured":"Schrezenmeier J and Huntly BJP. Epigenetic dysregulation in acute myeloid leukemia. Semin Hematol 2025; 62: 177-186.","journal-title":"Semin Hematol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1404135","DOI":"10.3389\/fonc.2024.1404135","article-title":"Global burden and trends of leukemia attributable to high body mass index risk in adults over the past 30 years","volume":"14","author":"Xiao","year":"2024","unstructured":"Xiao H, Hu X, Li P and Deng J. Global burden and trends of leukemia attributable to high body mass index risk in adults over the past 30 years. Front Oncol 2024; 14: 1404135.","journal-title":"Front Oncol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/stmcls\/sxad095","article-title":"Aberrant lipid metabolic signatures in acute myeloid leukemia","volume":"42","author":"Singh","year":"2024","unstructured":"Singh P, Murali R, Shanmugam SG, Thomas S, Scott J, Warrier S, Arfuso F, Dharmarajan A and Gandhirajan RK. Aberrant lipid metabolic signatures in acute myeloid leukemia. Stem Cells 2024; 42: 200-215.","journal-title":"Stem Cells"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"100950","DOI":"10.1016\/j.blre.2022.100950","article-title":"Harnessing the power of sphingolipids: prospects for acute myeloid leukemia","volume":"55","author":"Ung","year":"2022","unstructured":"Ung J, Tan SF, Fox TE, Shaw JJP, Vass LR, Costa-Pinheiro P, Garrett-Bakelman FE, Keng MK, Sharma A, Claxton DF, Levine RL, Tallman MS, Cabot MC, Kester M, Feith DJ and Loughran TP Jr. Harnessing the power of sphingolipids: prospects for acute myeloid leukemia. Blood Rev 2022; 55: 100950.","journal-title":"Blood Rev"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"5793","DOI":"10.3390\/ijms22115793","article-title":"A comprehensive review: sphingolipid metabolism and implications of disruption in sphingolipid homeostasis","volume":"22","author":"Quinville","year":"2021","unstructured":"Quinville BM, Deschenes NM, Ryckman AE and Walia JS. A comprehensive review: sphingolipid metabolism and implications of disruption in sphingolipid homeostasis. Int J Mol Sci 2021; 22: 5793.","journal-title":"Int J Mol Sci"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"102262","DOI":"10.1016\/j.anaerobe.2020.102262","article-title":"Clostridium perfringens α-toxin specifically induces endothelial cell death by promoting ceramide-mediated apoptosis","volume":"65","author":"Takehara","year":"2020","unstructured":"Takehara M, Bandou H, Kobayashi K and Nagahama M. Clostridium perfringens α-toxin specifically induces endothelial cell death by promoting ceramide-mediated apoptosis. Anaerobe 2020; 65: 102262.","journal-title":"Anaerobe"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/MOH.0000000000000853","article-title":"Unraveling lipid metabolism for acute myeloid leukemia therapy","volume":"32","author":"O&#x2019","year":"2025","unstructured":"O’Brien C and Jones CL. Unraveling lipid metabolism for acute myeloid leukemia therapy. Curr Opin Hematol 2025; 32: 77-86.","journal-title":"Curr Opin Hematol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41598-021-04009-w","article-title":"The sphingosine 1-phosphate receptor 2\/4 antagonist JTE-013 elicits off-target effects on sphingolipid metabolism","volume":"12","author":"Pitman","year":"2022","unstructured":"Pitman MR, Lewis AC, Davies LT, Moretti PAB, Anderson D, Creek DJ, Powell JA and Pitson SM. The sphingosine 1-phosphate receptor 2\/4 antagonist JTE-013 elicits off-target effects on sphingolipid metabolism. Sci Rep 2022; 12: 454.","journal-title":"Sci Rep"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Zhao Z, Xu S, Ma J, Zhang Z, Liang S and Guo J. Macrophage CBX4 potentiates atherosclerosis by its SUMO E3 ligase activity. Cardiovasc Drugs Ther 2025; [Epub ahead of print].","DOI":"10.1007\/s10557-025-07724-y"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Li H, Xu Y, Zheng Y, Xue Z, Li Q, Jia X, Weng L, Jiang L, Ruan X, Zhang R, Yin Y, Zhou L, Li F, Huang H, Li J, Tan M, Fan J, Cai J, Chen G and Zhou L. CBX4 acetoacetylation as an inhibitory mechanism of HIF-1α activity. Cell Chem Biol 2025; 32: 1249-1259, e9.","DOI":"10.1016\/j.chembiol.2025.09.005"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"119524","DOI":"10.1016\/j.bbamcr.2023.119524","article-title":"Cbx4 governs HIF-1α to involve in Th9 cell differentiation promoting asthma by its SUMO E3 ligase activity","volume":"1870","author":"Huang","year":"2023","unstructured":"Huang W, Yu C, Wu H, Liang S, Kang J, Zhou Z, Liu A and Liu L. Cbx4 governs HIF-1α to involve in Th9 cell differentiation promoting asthma by its SUMO E3 ligase activity. Biochim Biophys Acta Mol Cell Res 2023; 1870: 119524.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/stcltm\/szad090","article-title":"Histone Trimethylations and HDAC5 regulate spheroid subpopulation and differentiation signaling of human adipose-derived stem cells","volume":"13","author":"Chang","year":"2024","unstructured":"Chang MM, Hong YK, Hsu CK, Harn HI, Huang BM, Liu YH, Lu FI, Hsueh YY, Lin SP and Wu CC. Histone Trimethylations and HDAC5 regulate spheroid subpopulation and differentiation signaling of human adipose-derived stem cells. Stem Cells Transl Med 2024; 13: 293-308.","journal-title":"Stem Cells Transl Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"102692","DOI":"10.1016\/j.ebiom.2020.102692","article-title":"CBX4 transcriptionally suppresses KLF6 via interaction with HDAC1 to exert oncogenic activities in clear cell renal cell carcinoma","volume":"53","author":"Jiang","year":"2020","unstructured":"Jiang N, Niu G, Pan YH, Pan W, Zhang MF, Zhang CZ and Shen H. CBX4 transcriptionally suppresses KLF6 via interaction with HDAC1 to exert oncogenic activities in clear cell renal cell carcinoma. EBioMedicine 2020; 53: 102692.","journal-title":"EBioMedicine"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1038\/s41467-025-56891-x","article-title":"CerS6 links ceramide metabolism to innate immune responses in diabetic kidney disease","volume":"16","author":"Zhu","year":"2025","unstructured":"Zhu Z, Cao Y, Jian Y, Hu H, Yang Q, Hao Y, Jiang H, Luo Z, Yang X, Li W, Hu J, Liu H, Liang W, Ding G and Chen Z. CerS6 links ceramide metabolism to innate immune responses in diabetic kidney disease. Nat Commun 2025; 16: 1528.","journal-title":"Nat Commun"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.freeradbiomed.2024.12.018","article-title":"Ceramide synthase 6 induces mitochondrial dysfunction and apoptosis in hemin-treated neurons by impairing mitophagy through interacting with sequestosome 1","volume":"227","author":"Xu","year":"2025","unstructured":"Xu A, Liu Y, Wang B, Zhang Q, Ma Y, Xue Y, Wang Z, Sun Q, Sun Y and Bian L. Ceramide synthase 6 induces mitochondrial dysfunction and apoptosis in hemin-treated neurons by impairing mitophagy through interacting with sequestosome 1. Free Radic Biol Med 2025; 227: 282-295.","journal-title":"Free Radic Biol Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"11949","DOI":"10.1111\/jcmm.15817","article-title":"CERS6 required for cell migration and metastasis in lung cancer","volume":"24","author":"Suzuki","year":"2020","unstructured":"Suzuki M, Cao K, Kato S, Mizutani N, Tanaka K, Arima C, Tai MC, Nakatani N, Yanagisawa K, Takeuchi T, Shi H, Mizutani Y, Niimi A, Taniguchi T, Fukui T, Yokoi K, Wakahara K, Hasegawa Y, Mizutani Y, Iwaki S, Fujii S, Satou A, Tamiya-Koizumi K, Murate T, Kyogashima M, Tomida S and Takahashi T. CERS6 required for cell migration and metastasis in lung cancer. J Cell Mol Med 2020; 24: 11949-11959.","journal-title":"J Cell Mol Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.biocel.2019.05.002","article-title":"GPER1 influences cellular homeostasis and cytostatic drug resistance via influencing long chain ceramide synthesis in breast cancer cells","volume":"112","author":"MS","year":"2019","unstructured":"Wegner MS, Gruber L, Schömel N, Trautmann S, Brachtendorf S, Fuhrmann D, Schreiber Y, Olesch C, Brüne B, Geisslinger G and Grösch S. GPER1 influences cellular homeostasis and cytostatic drug resistance via influencing long chain ceramide synthesis in breast cancer cells. Int J Biochem Cell Biol 2019; 112: 95-106.","journal-title":"Int J Biochem Cell Biol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.6004\/jnccn.2021.0002","article-title":"2021","volume":"19","author":"Pollyea","year":"2021","unstructured":"Pollyea DA, Bixby D, Perl A, Bhatt VR, Altman JK, Appelbaum FR, de Lima M, Fathi AT, Foran JM, Gojo I, Hall AC, Jacoby M, Lancet J, Mannis G, Marcucci G, Martin MG, Mims A, Neff J, Nejati R, Olin R, Percival ME, Prebet T, Przespolewski A, Rao D, Ravandi-Kashani F, Shami PJ, Stone RM, Strickland SA, Sweet K, Vachhani P, Wieduwilt M, Gregory KM, Ogba N and Tallman MS. NCCN guidelines insights: acute myeloid leukemia, version 2.2021. J Natl Compr Canc Netw 2021; 19: 16-27.","journal-title":"J Natl Compr Canc Netw"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"8517","DOI":"10.1038\/s41598-024-57295-5","article-title":"Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemia","volume":"14","author":"Song","year":"2024","unstructured":"Song GY, Kim HJ, Kim T, Ahn SY, Jung SH, Kim M, Yang DH, Lee JJ, Kim MY, Cheong JW, Jung CW, Jang JH, Kim HJ, Moon JH, Sohn SK, Won JH, Park SK, Kim SH, Choi CK, Kim HJ, Ahn JS and Kim DDH. Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemia. Sci Rep 2024; 14: 8517.","journal-title":"Sci Rep"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1182\/bloodadvances.2021006166","article-title":"Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy","volume":"6","author":"Versluis","year":"2022","unstructured":"Versluis J, Pandey M, Flamand Y, Haydu JE, Belizaire R, Faber M, Vedula RS, Charles A, Copson KM, Shimony S, Rozental A, Bendapudi PK, Wolach O, Griffiths EA, Thompson JE, Stone RM, DeAngelo DJ, Neuberg D, Luskin MR, Wang ES and Lindsley RC. Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy. Blood Adv 2022; 6: 2835-2846.","journal-title":"Blood Adv"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Ito H, Nakamae I, Kato JY and Yoneda-Kato N. Stabilization of fatty acid synthesis enzyme acetyl-CoA carboxylase 1 suppresses acute myeloid leukemia development. J Clin Invest 2021; 131: e141529.","DOI":"10.1172\/JCI141529"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1182\/blood-2024-204333","article-title":"Elucidating transcriptional heterogeneity in venetoclax resistant AMLs","volume":"144","author":"Mohanty","year":"2024","unstructured":"Mohanty V, Baran N, Huang Y, Ramage CL, Cooper L, Pelletier SG, He S, Iqbal R, Daher M and Tyner JW. Elucidating transcriptional heterogeneity in venetoclax resistant AMLs. Blood 2024; 144: 2753.","journal-title":"Blood"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/s43018-020-00126-z","article-title":"Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells","volume":"1","author":"BM","year":"2020","unstructured":"Stevens BM, Jones CL, Pollyea DA, Culp-Hill R, D’Alessandro A, Winters A, Krug A, Abbott D, Goosman M, Pei S, Ye H, Gillen AE, Becker MW, Savona MR, Smith C and Jordan CT. Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells. Nat Cancer 2020; 1: 1176-1187.","journal-title":"Nat Cancer"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.annonc.2022.11.004","article-title":"Moving toward individualized target-based therapies in acute myeloid leukemia","volume":"34","author":"Bazinet","year":"2023","unstructured":"Bazinet A and Kantarjian HM. Moving toward individualized target-based therapies in acute myeloid leukemia. Ann Oncol 2023; 34: 141-151.","journal-title":"Ann Oncol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"5988","DOI":"10.3390\/ijms24065988","article-title":"Variation in lipid species profiles among leukemic cells significantly impacts their sensitivity to the drug targeting of lipid metabolism and the prognosis of AML patients","volume":"24","author":"Presti C","year":"2023","unstructured":"Lo Presti C, Yamaryo-Botté Y, Mondet J, Berthier S, Nutiu D, Botté C and Mossuz P. Variation in lipid species profiles among leukemic cells significantly impacts their sensitivity to the drug targeting of lipid metabolism and the prognosis of AML patients. Int J Mol Sci 2023; 24: 5988.","journal-title":"Int J Mol Sci"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s11658-020-00209-w","article-title":"Adipose-derived stromal cells in regulation of hematopoiesis","volume":"25","author":"Zhang","year":"2020","unstructured":"Zhang J, Liu Y, Yin W and Hu X. Adipose-derived stromal cells in regulation of hematopoiesis. Cell Mol Biol Lett 2020; 25: 16.","journal-title":"Cell Mol Biol Lett"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/cam4.2675","article-title":"Long noncoding RNA CERS6-AS1 functions as a malignancy promoter in breast cancer by binding to IGF2BP3 to enhance the stability of CERS6 mRNA","volume":"9","author":"Bao","year":"2020","unstructured":"Bao G, Huang J, Pan W, Li X and Zhou T. Long noncoding RNA CERS6-AS1 functions as a malignancy promoter in breast cancer by binding to IGF2BP3 to enhance the stability of CERS6 mRNA. Cancer Med 2020; 9: 278-289.","journal-title":"Cancer Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1002\/mc.22888","article-title":"Ceramide synthase 6 predicts the prognosis of human gastric cancer: it functions as an oncoprotein by dysregulating the SOCS2\/JAK2\/STAT3 pathway","volume":"57","author":"Uen","year":"2018","unstructured":"Uen YH, Fang CL, Lin CC, Hseu YC, Hung ST, Sun DP and Lin KY. Ceramide synthase 6 predicts the prognosis of human gastric cancer: it functions as an oncoprotein by dysregulating the SOCS2\/JAK2\/STAT3 pathway. Mol Carcinog 2018; 57: 1675-1689.","journal-title":"Mol Carcinog"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1111\/cas.14928","article-title":"CEBPγ facilitates lamellipodia formation and cancer cell migration through CERS6 upregulation","volume":"112","author":"Shi","year":"2021","unstructured":"Shi H, Niimi A, Takeuchi T, Shiogama K, Mizutani Y, Kajino T, Inada K, Hase T, Hatta T, Shibata H, Fukui T, Chen-Yoshikawa TF, Nagano K, Murate T, Kawamoto Y, Tomida S, Takahashi T and Suzuki M. CEBPγ facilitates lamellipodia formation and cancer cell migration through CERS6 upregulation. Cancer Sci 2021; 112: 2770-2780.","journal-title":"Cancer Sci"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"8259","DOI":"10.1038\/s41598-021-87795-7","article-title":"Ceramide kinase regulates TNF-α-induced immune responses in human monocytic cells","volume":"11","author":"Al-Rashed","year":"2021","unstructured":"Al-Rashed F, Ahmad Z, Snider AJ, Thomas R, Kochumon S, Melhem M, Sindhu S, Obeid LM, Al-Mulla F, Hannun YA and Ahmad R. Ceramide kinase regulates TNF-α-induced immune responses in human monocytic cells. Sci Rep 2021; 11: 8259.","journal-title":"Sci Rep"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"117740","DOI":"10.1016\/j.cca.2023.117740","article-title":"The potential serum sphingolipid biomarkers for distinguishing Wilson disease","volume":"553","author":"Tang","year":"2024","unstructured":"Tang S, Liang C, Yu H, Hou W, Hu Z, Chen X, Duan Z and Zheng S. The potential serum sphingolipid biomarkers for distinguishing Wilson disease. Clin Chim Acta 2024; 553: 117740.","journal-title":"Clin Chim Acta"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"7277","DOI":"10.1158\/0008-5472.CAN-16-2100","article-title":"CBX4 suppresses metastasis via recruitment of HDAC3 to the Runx2 promoter in colorectal carcinoma","volume":"76","author":"Wang","year":"2016","unstructured":"Wang X, Li L, Wu Y, Zhang R, Zhang M, Liao D, Wang G, Qin G, Xu RH and Kang T. CBX4 suppresses metastasis via recruitment of HDAC3 to the Runx2 promoter in colorectal carcinoma. Cancer Res 2016; 76: 7277-7289.","journal-title":"Cancer Res"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1016\/j.celrep.2018.02.057","article-title":"Cbx4 sumoylates Prdm16 to regulate adipose tissue thermogenesis","volume":"22","author":"Chen","year":"2018","unstructured":"Chen Q, Huang L, Pan D, Zhu LJ and Wang YX. Cbx4 sumoylates Prdm16 to regulate adipose tissue thermogenesis. Cell Rep 2018; 22: 2860-2872.","journal-title":"Cell Rep"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12964-021-00797-w","article-title":"CBX4-dependent regulation of HDAC3 nuclear translocation reduces Bmp2-induced osteoblastic differentiation and calcification in adamantinomatous craniopharyngioma","volume":"20","author":"Yan","year":"2022","unstructured":"Yan X, Kang D, Lin Y, Qi S and Jiang C. CBX4-dependent regulation of HDAC3 nuclear translocation reduces Bmp2-induced osteoblastic differentiation and calcification in adamantinomatous craniopharyngioma. Cell Commun Signal 2022; 20: 3.","journal-title":"Cell Commun Signal"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"661620","DOI":"10.3389\/fonc.2021.661620","article-title":"Insights into the function and clinical application of HDAC5 in cancer management","volume":"11","author":"Yang","year":"2021","unstructured":"Yang J, Gong C, Ke Q, Fang Z, Chen X, Ye M and Xu X. Insights into the function and clinical application of HDAC5 in cancer management. Front Oncol 2021; 11: 661620.","journal-title":"Front Oncol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1158\/0008-5472.CAN-20-2828","article-title":"HDAC5 loss impairs RB repression of pro-oncogenic genes and confers CDK4\/6 inhibitor resistance in cancer","volume":"81","author":"Zhou","year":"2021","unstructured":"Zhou Y, Jin X, Ma J, Ding D, Huang Z, Sheng H, Yan Y, Pan Y, Wei T, Wang L, Wu H and Huang H. HDAC5 loss impairs RB repression of pro-oncogenic genes and confers CDK4\/6 inhibitor resistance in cancer. Cancer Res 2021; 81: 1486-1499.","journal-title":"Cancer Res"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.identj.2022.08.007","article-title":"HDAC5-mediated acetylation of p100 suppresses its processing","volume":"73","author":"Wang","year":"2023","unstructured":"Wang J, Wu S, Liu L, Pang Y, Li Z and Mu H. HDAC5-mediated acetylation of p100 suppresses its processing. Int Dent J 2023; 73: 387-394.","journal-title":"Int Dent J"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"119504","DOI":"10.1016\/j.lfs.2021.119504","article-title":"Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy","volume":"277","author":"MJ","year":"2021","unstructured":"Ramaiah MJ, Tangutur AD and Manyam RR. Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy. Life Sci 2021; 277: 119504.","journal-title":"Life Sci"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.reprotox.2021.10.008","article-title":"Repression of HDAC5 by acetate restores hypothalamic-pituitary-ovarian function in type 2 diabetes mellitus","volume":"106","author":"Olaniyi","year":"2021","unstructured":"Olaniyi KS, Amusa OA, Ajadi IO, Alabi BY, Agunbiade TB and Ajadi MB. Repression of HDAC5 by acetate restores hypothalamic-pituitary-ovarian function in type 2 diabetes mellitus. Reprod Toxicol 2021; 106: 69-81.","journal-title":"Reprod Toxicol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"110789","DOI":"10.1016\/j.cellsig.2023.110789","article-title":"GNA13 inhibits glioblastoma metastasis via the ERKs\/FOXO3 signaling pathway","volume":"109","author":"Yi","year":"2023","unstructured":"Yi Q, Huang M, Zhang X, Xu Z, Sun J, Wang S, Xu H, Du Z and Liu M. GNA13 inhibits glioblastoma metastasis via the ERKs\/FOXO3 signaling pathway. Cell Signal 2023; 109: 110789.","journal-title":"Cell Signal"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"7726","DOI":"10.1074\/jbc.RA119.011984","article-title":"Knockout mouse models reveal the contributions of G protein subunits to complement C5a receptor-mediated chemotaxis","volume":"295","author":"van den Bos","year":"2020","unstructured":"van den Bos E, Ambrosy B, Horsthemke M, Walbaum S, Bachg AC, Wettschureck N, Innamorati G, Wilkie TM and Hanley PJ. Knockout mouse models reveal the contributions of G protein subunits to complement C5a receptor-mediated chemotaxis. J Biol Chem 2020; 295: 7726-7742.","journal-title":"J Biol Chem"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/s41419-018-0528-7","article-title":"Long non-coding RNA Lnc-Tim3 exacerbates CD8 T cell exhaustion via binding to Tim-3 and inducing nuclear translocation of Bat3 in HCC","volume":"9","author":"Ji","year":"2018","unstructured":"Ji J, Yin Y, Ju H, Xu X, Liu W, Fu Q, Hu J, Zhang X and Sun B. Long non-coding RNA Lnc-Tim3 exacerbates CD8 T cell exhaustion via binding to Tim-3 and inducing nuclear translocation of Bat3 in HCC. Cell Death Dis 2018; 9: 478.","journal-title":"Cell Death Dis"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.7150\/thno.95748","article-title":"CBX4 suppresses CD8(+) T cell antitumor immunity by reprogramming glycolytic metabolism","volume":"14","author":"Wang","year":"2024","unstructured":"Wang J, Jia W, Zhou X, Ma Z, Liu J and Lan P. CBX4 suppresses CD8(+) T cell antitumor immunity by reprogramming glycolytic metabolism. Theranostics 2024; 14: 3793-3809.","journal-title":"Theranostics"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.7150\/jca.115613","article-title":"Integrating single-cell and bulk RNA sequencing reveals the malignant phenotype of CBX4 in prostate cancer","volume":"16","author":"Liu","year":"2025","unstructured":"Liu Z, Liu Y, Fu Z, Huang H, Wang R, Wang Z, Peng S, Wang J, Fang Z and Liu L. Integrating single-cell and bulk RNA sequencing reveals the malignant phenotype of CBX4 in prostate cancer. J Cancer 2025; 16: 3525-3536.","journal-title":"J Cancer"}],"container-title":["American Journal of Cancer Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajcr\/15\/11\/ajcr0168238.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T02:57:12Z","timestamp":1768964232000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcr\/15\/11\/ajcr0168238.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":45,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/vxbp2060","relation":{},"ISSN":["2156-6976"],"issn-type":[{"value":"2156-6976","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}